There is some evidence that Covid 19 pneumonia is associated with prothrombotic status
and increased risk of venous thromboembolic events (deep venous thrombosis and …

CORRESPONDENCE on admission and acute degradation of hemodynamic or respiratory
status. All CTPAs were performed with multibar computed tomography with no difference in …

Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant
contributor to the morbidity and mortality associated with COVID-19. In this study, we utilized …

Objectives During the COVID-19 pandemic, several studies described an increased chance
of developing pulmonary embolism (PE). Several scores have been used to predict the …

Purpose Pulmonary embolism (PE) in COVID-19 patients can play a key role in precipitating
clinical conditions. We aimed to evaluate PE distribution on CTA and to investigate any …

Objectives To identify which level of D-dimer would allow the safe exclusion of pulmonary
embolism (PE) in COVID-19 patients presenting to the emergency department (ED) …

Objective To determine the predictive factors of pulmonary thromboembolic (PTE) in patients
with SARS-CoV-2 infection (COVID-19) assessed in the emergency department at a tertiary …

Infection by SARS-Cov-2 is mainly characterized by fever and respiratory symptoms, with
dyspnea and lung infiltrates in more severe cases [1]. Many patients also present with a pro …

For more than 2 decades, the plasma D-dimer assay has been used in conjunction with
clinical prediction scores to rule out pulmonary embolism (PE) among patients with a low …

Recent reports have suggested an increased risk of pulmonary embolism (PE) related to
COVID-19. The aim of this cohort study is to compare the incidence of PE during a 3-year …